Correspondence 0001193125-23-221460 from Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc.
Date: Aug. 25, 2023 · CIK: 0001830214 · Accession: 0001193125-23-221460
AI Filing Summary & Sentiment
File numbers found in text: 333-274171
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Ginkgo Bioworks Holdings, Inc.
27 Drydock Avenue
8th Floor
Boston, MA 02210
August 25,
2023
VIA EDGAR
Securities and Exchange
Commission
Division of Corporation Finance
100 F Street,
N.E.
Washington, D.C. 20549
Attention:
Daniel Crawford
Re:
Ginkgo Bioworks Holdings, Inc.
Registration Statement on Form S-3 (File
No. 333-274171)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules
and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Ginkgo Bioworks Holdings, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for
the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on August 29, 2023, or as soon as possible thereafter. The Company hereby authorizes Marko Zatylny of Ropes &
Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please contact Marko Zatylny (marko.zatylny@ropesgray.com)
/ telephone: (617) 951-7980 of Ropes & Gray LLP as soon as the registration statement has been declared effective.
[Signature page follows]
Very truly yours,
GINKGO BIOWORKS HOLDINGS, INC.
By:
/s/ Mark Dmytruk
Name:
Mark Dmytruk
Title:
Chief Financial Officer
[Signature Page to Acceleration Request]